Bulgaria · Delayed Price · Currency is EUR Biodit AD Statistics
Total Valuation
Biodit AD has a market cap or net worth of EUR 1.47 million. The enterprise value is 1.81 million.
| Market Cap | 1.47M |
| Enterprise Value | 1.81M |
Important Dates
The next estimated earnings date is Tuesday, December 1, 2026.
| Earnings Date | Dec 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biodit AD has 14.82 million shares outstanding.
| Current Share Class | 14.82M |
| Shares Outstanding | 14.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 68.35% |
| Owned by Institutions (%) | 12.34% |
| Float | 3.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.37 |
| PB Ratio | 0.27 |
| P/TBV Ratio | 2.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.24, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.24 |
| Quick Ratio | 0.34 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.96 |
Financial Efficiency
Return on equity (ROE) is -3.81% and return on invested capital (ROIC) is -2.00%.
| Return on Equity (ROE) | -3.81% |
| Return on Assets (ROA) | -1.99% |
| Return on Invested Capital (ROIC) | -2.00% |
| Return on Capital Employed (ROCE) | -3.42% |
| Weighted Average Cost of Capital (WACC) | 6.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 8 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.46% in the last 52 weeks. The beta is 0.49, so Biodit AD's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -35.46% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.28 |
| Relative Strength Index (RSI) | 46.55 |
| Average Volume (20 Days) | 2,102 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biodit AD had revenue of EUR 129,083 and -217,168 in losses. Loss per share was -0.01.
| Revenue | 129,083 |
| Gross Profit | 112,518 |
| Operating Income | -195,460 |
| Pretax Income | -217,168 |
| Net Income | -217,168 |
| EBITDA | -90,404 |
| EBIT | -195,460 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 48,000 in cash and 387,000 in debt, with a net cash position of -339,000 or -0.02 per share.
| Cash & Cash Equivalents | 48,000 |
| Total Debt | 387,000 |
| Net Cash | -339,000 |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | 5.52M |
| Book Value Per Share | 0.37 |
| Working Capital | 678,000 |
Cash Flow
| Operating Cash Flow | -11,370 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 105,056 |
| Net Borrowing | -15,514 |
| Free Cash Flow | -11,370 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 87.17%, with operating and profit margins of -151.42% and -168.24%.
| Gross Margin | 87.17% |
| Operating Margin | -151.42% |
| Pretax Margin | -168.24% |
| Profit Margin | -168.24% |
| EBITDA Margin | -70.04% |
| EBIT Margin | -151.42% |
| FCF Margin | n/a |
Dividends & Yields
Biodit AD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -14.80% |
| FCF Yield | -0.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biodit AD has an Altman Z-Score of 2.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.94 |
| Piotroski F-Score | 1 |